These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20018815)

  • 1. Molecular epidemiology of pediatric pneumococcal empyema from 2001 to 2007 in Utah.
    Byington CL; Hulten KG; Ampofo K; Sheng X; Pavia AT; Blaschke AJ; Pettigrew M; Korgenski K; Daly J; Mason EO
    J Clin Microbiol; 2010 Feb; 48(2):520-5. PubMed ID: 20018815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.
    Byington CL; Korgenski K; Daly J; Ampofo K; Pavia A; Mason EO
    Pediatr Infect Dis J; 2006 Mar; 25(3):250-4. PubMed ID: 16511389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained high prevalence of pneumococcal serotype 1 in paediatric parapneumonic empyema in southern Spain from 2005 to 2009.
    Obando I; Camacho-Lovillo MS; Porras A; Gandía-González MA; Molinos A; Vazquez-Barba I; Morillo-Gutierrez B; Neth OW; Tarrago D
    Clin Microbiol Infect; 2012 Aug; 18(8):763-8. PubMed ID: 21910779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal disease: emergence of serotypes 19A and 7F following conjugate pneumococcal vaccination in a Mexican hospital.
    Chacon-Cruz E; Velazco-Mendez Y; Navarro-Alvarez S; Rivas-Landeros RM; Volker ML; Lopez-Espinoza G
    J Infect Dev Ctries; 2012 Jun; 6(6):516-20. PubMed ID: 22706195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Negreira S; Del Castillo F; Hernández-Sampelayo T; Bueno M; Calvo C; Ríos E; Méndez C;
    Pediatr Infect Dis J; 2011 Jun; 30(6):471-4. PubMed ID: 21266938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Streptococcus pneumoniae-induced hemolytic uremic syndrome in Utah children.
    Bender JM; Ampofo K; Byington CL; Grinsell M; Korgenski K; Daly JA; Mason EO; Pavia AT
    Pediatr Infect Dis J; 2010 Aug; 29(8):712-6. PubMed ID: 20661100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.
    Kendall BA; Dascomb KK; Mehta RR; Mason EO; Ampofo K; Pombo DJ; Pavia AT; Byington CL
    Vaccine; 2011 Nov; 29(49):9123-6. PubMed ID: 22001280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
    Pelton SI; Huot H; Finkelstein JA; Bishop CJ; Hsu KK; Kellenberg J; Huang SS; Goldstein R; Hanage WP
    Pediatr Infect Dis J; 2007 Jun; 26(6):468-72. PubMed ID: 17529860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of Streptococcus pneumoniae serotypes that cause parapneumonic empyema in Turkey.
    Ceyhan M; Ozsurekci Y; Gürler N; Ozkan S; Sensoy G; Belet N; Hacimustafaoglu M; Celebi S; Keser M; Dinleyici EC; Alhan E; Baki A; Oner AF; Uzun H; Kurugol Z; Aycan AE; Gurbuz V; Karadag Oncel E; Celik M; Ozkaya Parlakay A
    Clin Vaccine Immunol; 2013 Jul; 20(7):972-6. PubMed ID: 23637041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
    Goettler D; Streng A; Kemmling D; Schoen C; von Kries R; Rose MA; van der Linden M; Liese JG
    Vaccine; 2020 Jan; 38(3):570-577. PubMed ID: 31735502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Streptococcus pneumoniae serotype changes in Utah adults after the introduction of PCV13 in children.
    Kendall BA; Dascomb KK; Mehta RR; Stockmann C; Mason EO; Ampofo K; Pavia AT; Byington CL
    Vaccine; 2016 Jan; 34(4):474-478. PubMed ID: 26706276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
    Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
    Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal analysis of invasive pneumococcal clones from Scotland illustrates fluctuations in diversity of serotype and genotype in the absence of pneumococcal conjugate vaccine.
    Jefferies JM; Smith AJ; Edwards GF; McMenamin J; Mitchell TJ; Clarke SC
    J Clin Microbiol; 2010 Jan; 48(1):87-96. PubMed ID: 19923488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population structure of invasive Streptococcus pneumoniae isolates in Italy prior to the implementation of the 7-valent conjugate vaccine (1999-2003).
    Gherardi G; D'Ambrosio F; Monaco M; Camilli R; De Florio L; D'Ancona F; Dicuonzo G; Pantosti A
    Eur J Clin Microbiol Infect Dis; 2009 Jan; 28(1):99-103. PubMed ID: 18663502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
    Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
    J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of pneumococcal 19A empyema in UK children.
    Thomas MF; Sheppard CL; Guiver M; Slack MP; George RC; Gorton R; Paton JY; Simmister C; Cliff D; Elemraid MA; Clark JE; Rushton SP; Spencer DA
    Arch Dis Child; 2012 Dec; 97(12):1070-2. PubMed ID: 23076341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsular serotypes and antimicrobial susceptibilities of Streptococcus pneumoniae causing invasive pneumococcal disease from 2009-2012 with an emphasis on serotype 19A in bacteraemic pneumonia and empyema and β-lactam resistance.
    Lee MR; Chen CM; Chuang TY; Huang YT; Hsueh PR
    Int J Antimicrob Agents; 2013 Nov; 42(5):395-402. PubMed ID: 24071028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona.
    Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R
    J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of serotype and genotype in Streptococcus pneumoniae isolates from a Korean hospital in 2007.
    Song JH; Baek JY; Cheong HS; Chung DR; Peck KR; Ko KS
    Diagn Microbiol Infect Dis; 2009 Mar; 63(3):271-8. PubMed ID: 19179034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.